← Leaderboards
Andrew Getahun
University Of Colorado Denver
$1,498,364
Attributed
$1,498,364
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $541.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,498,364 · 2
By mechanism
R01$1,083,816 · 1
R21$414,548 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Roberta Pelanda$15,844,961
- Mayumi Fujita$5,471,263
- Susan A. Boackle$5,205,492
- Jon D Piganelli$2,805,931
- Mary Elaine Reyland$13,618,689
Others in their field
Other Emerging Leaders on “Prevent”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
- Kimberly Smith · Ppd Development Lp$115,671,664
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
PreventPtpn6 GeneInsightPlaySignal TransductionTyrosineImmune ToleranceInositolMediatingPhosphorylationReceptorRecruitBindingSrc-Family KinasesEquilibriumEventAutoreactive B CellB-LymphocytesItimMaintenanceMolecularPhosphoric Monoester HydrolasesBiochemicalAutoimmune Diseases
Grant awards (4)
CD79A as a molecular switch regulating B cell activation$541,908
R01 · FY2025 · AI · contact PI
CD79A as a molecular switch regulating B cell activation$541,908
R01 · FY2024 · AI · contact PI
Identification of novel Inhibitory receptors Involved In B cell tolerance$187,555
R21 · FY2021 · AI · contact PI
Identification of novel Inhibitory receptors Involved In B cell tolerance$226,993
R21 · FY2020 · AI · contact PI